A comprehensive, population level evaluation of previously reported drug triggers of pemphigus highlights immunomodulatory capacity as a common characteristic
QuestionCan previously reported, largely anecdotal associations between exposure to any of a comprehensive list of putative trigger drugs and the development of pemphigus be reproduced using population level data?FindingsIn this series of observational, retrospective, case-control, pharmacovigilance...
Saved in:
Main Authors: | Justin Baroukhian, Kristina Seiffert-Sinha, Animesh A. Sinha |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1508129/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation
by: Rebekah R. Schwartz, et al.
Published: (2025-01-01) -
The impact of signaling pathways on the desmosome ultrastructure in pemphigus
by: Thomas Schmitt, et al.
Published: (2025-01-01) -
Paraneoplastic pemphigus involved oral mucosa only: a case report and literature review
by: Xixi Yu, et al.
Published: (2025-01-01) -
Consensus Based Indian Guidelines for the Management of Pemphigus Vulgaris and Pemphigus Foliaceous
by: Dipankar De, et al.
Published: (2025-01-01) -
Immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroids
by: Vadim V. Chikin, et al.
Published: (2024-12-01)